Literature DB >> 7558303

Surface exposure of outer membrane protein and lipopolysaccharide epitopes in Brucella species studied by enzyme-linked immunosorbent assay and flow cytometry.

R A Bowden1, A Cloeckaert, M S Zygmunt, S Bernard, G Dubray.   

Abstract

Seven surface-exposed outer membrane proteins (OMPs) in Brucella supp. have been previously described (A. Cloeckaert, P. de Wergifosse, G. Dubray, and J. N. Limet, Infect. Immun. 58:3980-3987, 1990). OMPs were shown to be more accessible to monoclonal antibodies (MAbs) on rough (R) Brucella melitensis and B. abortus strains than to MAbs on their smooth (S) counterparts. In this work, we have extended this study to representatives of the main Brucella species, using MAbs specific for OMPs and S and R lipopolysaccharides (S-LPS and R-LPS). Enzyme-linked immunosorbent assay (ELISA), flow cytometry, and immunoelectron microscopy showed important differences between strains in the binding of OMP- and R-LPS-specific MAbs which were in part related to the particular expression of S-LPS, irrespective of the species. Results indicated that both the amount and the length of O polysaccharide on S-LPS greatly influenced the accessibility of OMP and R-LPS epitopes to MAbs. S-R B. melitensis EP and S B. suis 40, for instance, which express O-polysaccharide chains in small amounts and with short mean length, respectively, bound a greater number of OMP- and R-LPS-specific MAbs than the other S Brucella strains. The major 31- to 34-kDa OMP was the most exposed OMP on S strains of B. melitensis and B. suis. In most cases, flow cytometry results agreed with those of ELISA and supplied additional data, such as the homogeneity or heterogeneity of OMP expression at the strain level. However, there were some discordances between flow cytometry and ELISA results concerning the surface exposure of the 25- to 27-kDa and 31- to 34-kDa OMPs on S strains and that of minor OMPs in vaccine strain B. melitensis Rev.1. Immunoelectron microscopy confirmed the poor accessibility of OMPs to MAbs on the surface of S Brucella strains. The naturally R pathogenic species B. ovis and B. canis bound the majority of OMP-specific MAbs as well as the R-LPS-specific MAbs. Therefore, the conserved OMP and R-LPS epitopes could play a role as targets of protective antibody-mediated immunity in infections caused by naturally R B. ovis and B. canis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7558303      PMCID: PMC173554          DOI: 10.1128/iai.63.10.3945-3952.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

1.  Serum sensitivity and lipopolysaccharide characteristics in Bordetella bronchiseptica, B. pertussis and B. parapertussis.

Authors:  D W Byrd; R M Roop; H P Veit; G G Schurig
Journal:  J Med Microbiol       Date:  1991-03       Impact factor: 2.472

2.  Brucella melitensis Rev. 1 living attenuated vaccine: stability of markers, residual virulence and immunogenicity in mice.

Authors:  N Bosseray
Journal:  Biologicals       Date:  1991-10       Impact factor: 1.856

3.  SDS-soluble and peptidoglycan-bound proteins in the outer membrane-peptidoglycan complex of Brucella abortus.

Authors:  B A Sowa; K A Kelly; T A Ficht; M Frey; L G Adams
Journal:  Vet Microbiol       Date:  1991-05       Impact factor: 3.293

4.  Humoral immunity in mice mediated by monoclonal antibodies against the A and M antigens of Brucella.

Authors:  J N Limet; N Bosseray; B Garin-Bastuji; G Dubray; M Plommet
Journal:  J Med Microbiol       Date:  1989-09       Impact factor: 2.472

5.  Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting analysis of smooth-lipopolysaccharide heterogeneity among Brucella biovars related to A and M specificities.

Authors:  B Garin-Bastuji; R A Bowden; G Dubray; J N Limet
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

6.  Fine structure of A and M antigens from Brucella biovars.

Authors:  P J Meikle; M B Perry; J W Cherwonogrodzky; D R Bundle
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

7.  Protection conferred on mice by monoclonal antibodies directed against outer-membrane-protein antigens of Brucella.

Authors:  A Cloeckaert; I Jacques; N Bosseray; J N Limet; R Bowden; G Dubray; M Plommet
Journal:  J Med Microbiol       Date:  1991-03       Impact factor: 2.472

8.  Identification of seven surface-exposed Brucella outer membrane proteins by use of monoclonal antibodies: immunogold labeling for electron microscopy and enzyme-linked immunosorbent assay.

Authors:  A Cloeckaert; P de Wergifosse; G Dubray; J N Limet
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

9.  Biological properties of RB51; a stable rough strain of Brucella abortus.

Authors:  G G Schurig; R M Roop; T Bagchi; S Boyle; D Buhrman; N Sriranganathan
Journal:  Vet Microbiol       Date:  1991-07       Impact factor: 3.293

10.  Protection against Brucella melitensis or Brucella abortus in mice with immunoglobulin G (IgG), IgA, and IgM monoclonal antibodies specific for a common epitope shared by the Brucella A and M smooth lipopolysaccharides.

Authors:  A Cloeckaert; I Jacques; P de Wergifosse; G Dubray; J N Limet
Journal:  Infect Immun       Date:  1992-01       Impact factor: 3.441

View more
  45 in total

1.  Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis.

Authors:  L E Lindler; T L Hadfield; B D Tall; N J Snellings; F A Rubin; L L Van De Verg; D Hoover; R L Warren
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor alpha production during infection of human macrophages.

Authors:  V Jubier-Maurin; R A Boigegrain; A Cloeckaert; A Gross; M T Alvarez-Martinez; A Terraza; J Liautard; S Köhler; B Rouot; J Dornand; J P Liautard
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

3.  Comparative diagnostic evaluation of OMP31 gene based TaqMan® real-time PCR assay with visual LAMP assay and indirect ELISA for caprine brucellosis.

Authors:  Suman Saini; V K Gupta; K Gururaj; D D Singh; R V S Pawaiya; N K Gangwar; A K Mishra; Deepak Dwivedi; Dimple Andani; Ashok Kumar; T K Goswami
Journal:  Trop Anim Health Prod       Date:  2017-06-21       Impact factor: 1.559

4.  Subcellular fractions of Brucella ovis distinctively induce the production of interleukin-2, interleukin-4, and interferon-gamma in mice.

Authors:  E Salas-Téllez; A Núñez del Arco; V Tenorio; E Díaz-Aparicio; M de la Garza; F Suárez-Güemes
Journal:  Can J Vet Res       Date:  2005-01       Impact factor: 1.310

5.  Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2.

Authors:  Paula Barrionuevo; Juliana Cassataro; M Victoria Delpino; Astrid Zwerdling; Karina A Pasquevich; Clara García Samartino; Jorge C Wallach; Carlos A Fossati; Guillermo H Giambartolomei
Journal:  Infect Immun       Date:  2007-11-05       Impact factor: 3.441

6.  The lipopolysaccharide of Brucella abortus BvrS/BvrR mutants contains lipid A modifications and has higher affinity for bactericidal cationic peptides.

Authors:  Lorea Manterola; Ignacio Moriyón; Edgardo Moreno; Alberto Sola-Landa; David S Weiss; Michel H J Koch; Jörg Howe; Klaus Brandenburg; Ignacio López-Goñi
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

7.  Evidence of Brucella abortus OPS dictating uptake and restricting NF-kappaB activation in murine macrophages.

Authors:  Jianwu Pei; Joshua E Turse; Thomas A Ficht
Journal:  Microbes Infect       Date:  2008-01-20       Impact factor: 2.700

8.  Release of periplasmic proteins of Brucella suis upon acidic shock involves the outer membrane protein Omp25.

Authors:  Rose-Anne Boigegrain; Imed Salhi; Maria-Teresa Alvarez-Martinez; Jan Machold; Yann Fedon; Martine Arpagaus; Christoph Weise; Michael Rittig; Bruno Rouot
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  Effect of omp10 or omp19 deletion on Brucella abortus outer membrane properties and virulence in mice.

Authors:  Anne Tibor; Valérie Wansard; Valery Bielartz; Rose-May Delrue; Isabelle Danese; Patrick Michel; Karl Walravens; Jacques Godfroid; Jean-Jacques Letesson
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.

Authors:  Karina A Pasquevich; Silvia M Estein; Clara García Samartino; Clara García Samartino; Astrid Zwerdling; Lorena M Coria; Paula Barrionuevo; Carlos A Fossati; Guillermo H Giambartolomei; Juliana Cassataro
Journal:  Infect Immun       Date:  2008-11-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.